Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease

Area of Science:

• Neuroscience
• Immunology
• Gerontology

Background:

• Alzheimer's disease (AD) is a leading cause of dementia in older adults.
• Microglia-driven neuroinflammation is implicated in AD pathogenesis.
• Mechanisms linking microglia to neuroinflammation in AD are not fully understood.

Purpose of the Study:

• To review the role of mitochondrial dysfunction in microglial activation in AD.
• To explore the relationship between mitochondrial factors and neuroinflammation in AD.
• To discuss potential therapeutic strategies targeting microglial mitochondria in AD.

Main Methods:

• Literature review of recent studies on mitochondrial dysfunction and microglial activation in AD.
• Analysis of the roles of mitochondrial DNA (mtDNA), metabolism, and quality control (QC) in AD.
• Synthesis of current knowledge on the pathogenesis of AD.

Main Results:

• Mitochondrial dysfunction, including mtDNA damage, metabolic issues, and QC defects, precedes microglial activation.
• These mitochondrial changes in microglia are linked to neuroinflammation in AD.
• Understanding these links is crucial for AD research.

Conclusions:

• Mitochondrial dysfunction in microglia is a significant factor in AD.
• Targeting microglial mitochondria presents a promising therapeutic avenue for AD.
• Further research can lead to novel approaches for early AD diagnosis and treatment.